{"id":12,"date":"2024-05-30T07:33:55","date_gmt":"2024-05-30T07:33:55","guid":{"rendered":"https:\/\/www.buonmarrow.eu\/?page_id=12"},"modified":"2024-10-22T08:09:31","modified_gmt":"2024-10-22T08:09:31","slug":"home","status":"publish","type":"page","link":"https:\/\/www.buonmarrow.eu\/","title":{"rendered":"Home"},"content":{"rendered":"\n
\"\"<\/figure>
\n

Detecting cancer before it strikes again: <\/strong>pioneering Bone Marrow-on-Chip technology to predict tumor relapse and transform patient outcomes<\/p>\n<\/div><\/div>\n\n\n\n

OUR VISION<\/h1>\n\n\n\n

The vision of the EU-funded project BuonMarrow is to revolutionize cancer treatment by understanding and predicting cancer recurrence before it is visible through conventional methods. By developing a biological sensor for early detection of tumor relapse, our groundbreaking research aims to improve the survival rates of lung cancer patients.<\/p>\n\n\n\n

\n
DISCOVER MORE<\/a><\/div>\n<\/div>\n\n\n\n
\n\n\n\n

MULTIDISCIPLINARY TEAM<\/h2>\n\n\n\n

BuonMarrow brings together a multidisciplinary Consortium with complementary backgrounds<\/strong> from the clinical, biological and engineering fields, merging them to achieve a radically new approach at the frontier between preclinical research and clinical diagnosis:<\/p>\n\n\n\n

\n